GKZ: Counter, Differential Cell
What it covers
An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.
The identification in 21 CFR 864.5220, automated differential cell counter. FDA gives GKZ no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260781 | Yumizen H550 | HORIBA ABX SAS | Sep 14, 2026 | Traditional |
| K253212 | XR-Series (XR-10, XR-20) Automated Hematology Analyzers | Sysmex America, Inc. | May 27, 2026 | Traditional |
| K243348 | Athelas Home | Athelas, Inc. | Feb 6, 2026 | Traditional |
| K251249 | Tru Hematology Test | Truvian Sciences, Inc. | Jan 16, 2026 | Traditional |
| K250943 | Sysmex XR-Series (XR-10) Automated Hematology Analyzer | Sysmex America, Inc. | Jun 25, 2025 | Traditional |
| K251371 | Sysmex XR-Series (XR-20) Automated Hematology Analyzer | Sysmex America, Inc. | Jun 25, 2025 | Traditional |
| K243283 | Alinity h-series System | Abbott Laboratories | Feb 20, 2025 | Traditional |
| K240402 | Cito CBC System | Cytochip, Inc. | Feb 3, 2025 | Dual Track |
| K240252 | UniCel DxH 900 Coulter Cellular Analysis System; UniCel DxH Slidemaker Stainer II Coulter Cellular Analysis System; UniCel DxH 690T Coulter Cellular Analysis System | Beckman Coulter, Inc. | Jul 5, 2024 | Traditional |
| K232946 | Yumizen H2500 | HORIBA ABX SAS | May 21, 2024 | Traditional |
Clearances by year
47 GKZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 4 | 254 |
| 2025 | 4 | 108 |
| 2024 | 3 | 157 |
| 2023 | 4 | 329 |
| 2022 | 3 | 638 |
| 2020 | 1 | 156 |
| 2019 | 5 | 210 |
| 2018 | 3 | 270 |
| 2017 | 4 | 280 |
| 2016 | 3 | 198 |
| 2015 | 3 | 273 |
| 2014 | 3 | 165 |
| 2013 | 1 | 373 |
| 2012 | 3 | 408 |
| 2011 | 3 | 315 |
Who submits
19 applicants cleared a GKZ device since 2011. 72% of the clearances went to applicants in United States, then France (11%), Israel (11%) and China (4%). By type: Traditional 83%, Abbreviated 6%, Dual Track 6% and Special 4%.
| Applicant | Clearances since 2011 |
|---|---|
| Sysmex America, Inc. | 11 |
| HORIBA ABX SAS | 5 |
| Abbott Laboratories | 4 |
| Beckman Coulter, Inc. | 4 |
| Athelas, Inc. | 3 |
| Beckman Coulter | 3 |
| Diatron U.S., Inc. | 2 |
| Mindray Bio-Medical Electronics Co., Ltd. | 2 |
How FDA classifies it
Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”
From 21 CFR 864.5220. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 864.5220 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GKZ clearances declared.
Ask about GKZ
Questions about GKZ
What is FDA product code GKZ?
Product code GKZ, “Counter, Differential Cell” in FDA's classification database, is a Class II device type under 21 CFR 864.5220 (automated differential cell counter), reviewed by FDA's Hematology panel. FDA's 510(k) database lists 381 clearances under GKZ, 47 of them since 2011.
How many 510(k) clearances are there under GKZ?
FDA’s 510(k) database listed 381 clearances under GKZ as of Oct 29, 2026, 47 of them decided since 2011; the most recent decision was Sep 14, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a GKZ 510(k)?
For the 8 GKZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 214 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most GKZ clearances?
Since 2011: Sysmex America, Inc. (11), HORIBA ABX SAS (5), Abbott Laboratories (4), Beckman Coulter, Inc. (4) and Athelas, Inc. (3). 19 applicants have cleared a GKZ device in that time.